Contemporary etiology, outcomes, and therapy in pediatric myocarditis

Progress in Pediatric Cardiology

Volumn 31, Issue 2, 2011, Pages 123-128

  Foerster, S R ^a   Canter, C E ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Heart failure; Myocarditis; Outcomes; Therapy; Transplantation

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; CYCLOSPORIN; IMMUNOGLOBULIN; PREDNISONE;

ARTICLE; ASSISTED CIRCULATION; AUTOIMMUNITY; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; HEART MUSCLE BIOPSY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MYOCARDITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRIC CARDIOLOGY; PRIORITY JOURNAL; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TREATMENT INDICATION; VIRUS INFECTION; VIRUS MYOCARDITIS;

EID: 79955480133     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2011.02.010     Document Type: Article

References (71)

1. Aretz H.T. Diagnosis of myocarditis by endomyocardial biopsy. Med Clin North Am Nov 1986, 70(6):1215-1226.
2. Bowles NE, Bowles KR, Towbin JA. Viral genomic detection and outcome in myocarditis. Heart Fail Clin Oct 2005;1(3):407-17.
3. Andrews R.E., Fenton M.J., Ridout D.A., Burch M., British Congenital Cardiac Association New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United kingdom and Ireland. Circulation Jan 1 2008, 117(1):79-84. for the, Epub 2007 Dec 17.
4. Daubeney P.E., Nugent A.W., Chondros P., National Australian Childhood Cardiomyopathy Study, et al. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation Dec 12 2006, 114(24):2671-2678. for the, Epub 2006 Nov 20.
5. Nugent A.W., Daubeney P.E., Chondros P., National Australian Childhood Cardiomyopathy Study, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003 Apr 24, 348(17):1639-1646. for the.
6. Towbin J.A., Lowe A.M., Colan S.D., et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA Oct 18 2006, 296(15):1867-1876.
7. Renko M., Leskinen M., Kontiokari T., Tapiainen T., Hedberg P., Uhari M. Cardiac troponin-I as a screening tool for myocarditis in children hospitalized for viral infection. Acta Paediatr 2010 Feb, 99(2):283-285. Epub 2009 Nov 4.
8. Durani Y., Giordano K., Goudie B.W. Myocarditis and pericarditis in children. Pediatr Clin N Am Dec 2010, 57(6):1281-1303.
9. Kühl U., Schultheiss H.P. Viral myocarditis: diagnosis, aetiology and management. Drugs Jul 9 2009, 69(10):1287-1302.
10. Maron B.J., Doerer J.J., Haas T.S., Tierney D.M., Mueller F.O. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation Mar 3 2009, 119(8):1085-1092. Epub 2009 Feb 16.
11. Feldman A.M., McNamara D. Myocarditis. N Engl J Med Nov 9 2000, 343(19):1388-1398.
12. McCarthy R.E., Boehmer J.P., Hruban R.H., et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med Mar 9 2000, 342(10):690-695.
13. Amabile N., Fraisse A., Bouvenot J., Chetaille P., Ovaert C. Outcome of acute fulminant myocarditis in children. Heart Sep 2006, 92(9):1269-1273. Epub 2006 Jan 31.
14. Felker G.M., Boehmer J.P., Hruban R.H., et al. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol Jul 2000, 36(1):227-232.
15. Bowles N.E., Ni J., Kearney D.L., et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol Aug 6 2003, 42(3):466-472.
16. Kühl U., Pauschinger M., Noutsias M., et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation Feb 22 2005, 111(7):887-893. Epub 2005 Feb 7.
17. Kuethe F., Lindner J., Matschke K., et al. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis Dec 1 2009, 49(11):1660-1666.
18. Blauwet L.A., Cooper L.T. Myocarditis. Prog Cardiovasc Dis Jan-Feb 2010, 52(4):274-288.
19. Liu P.P., Mason J.W. Advances in the understanding of myocarditis. Circulation Aug 28 2001, 104(9):1076-1082.
20. Mahrholdt H., Goedecke C., Wagner A., et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation Mar 16 2004, 109(10):1250-1258. Epub 2004 Mar 1.
21. Kühl U., Pauschinger M., Schwimmbeck P.L., et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation Jun 10 2003, 107(22):2793-2798. Epub 2003 May 27.
22. Caforio A.L., Tona F., Bottaro S., Vinci A., Dequal G., Daliento L., Thiene G., Iliceto S. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity Feb 2008, 41(1):35-45.
23. Towbin J. Myocarditis. Heart disease in infants, children and adolescents 2001, 1197-1215. Lippincott Williams & Wilkins, Philadelphia. H.G. Allen, H.P. Gutgesell, E.B. Clark, D.J. Driscoll (Eds.).
24. Selinka H.C., Wolde A., Sauter M., Kandolf R., Klingel K. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism. Med Microbiol Immunol May 2004, 193(2-3):127-131. Epub 2003 Aug 14.
25. Shi Y., Chen C., Lisewski U., et al. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo. J Am Coll Cardiol Apr 7 2009, 53(14):1219-1226.
26. Davidoff R., Palacios I., Southern J., Fallon J.T., Newell J., Dec G.W. Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation Mar 1991, 83(3):953-961.
27. Franz W.M., Remppis A., Kandolf R., Kübler W., Katus H.A. Serum troponin T: diagnostic marker for acute myocarditis. Clin Chem Feb 1996, 42(2):340-341.
28. Lauer B., Niederau C., Kühl U., et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol Nov 1 1997, 30(5):1354-1359.
29. Soongswang J., Durongpisitkul K., Nana A., et al. Cardiac troponin T: a marker in the diagnosis of acute myocarditis in children. Pediatr Cardiol Jan-Feb 2005, 26(1):45-49.
30. Freedman S.B., Haladyn J.K., Floh A., Kirsh J.A., Taylor G., Thull-Freedman J. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics Dec 2007, 120(6):1278-1285.
31. Foerster S.R., Canter C.E., Cinar A., et al. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail Nov 1 2010, 3(6):689-697. Epub 2010 Sep 10.
32. Friedrich M.G., Sechtem U., Schulz-Menger J., International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol Apr 28 2009, 53(17):1475-1487. for the.
33. Vashist S., Woodard P., Grady R.M., Singh G. MRI characteristics of acute myocarditis in pediatric patients: patterns and predictors of outcome (abstract). J Am Coll Cardiol March 10 2009, A169. Abstract 1033-184.
34. Wagner A., Schulz-Menger J., Dietz R., Friedrich M.G. Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. Magma Feb 2003, 16(1):17-20.
35. Chow L.H., Radio S.J., Sears T.D., McManus B.M. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 1989 Oct, 14(4):915-920.
36. Pophal S.G., Sigfusson G., Booth K.L., et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol Dec 1999, 34(7):2105-2110.
37. Cooper L.T. Myocarditis. N Engl J Med Apr 9 2009, 360(15):1526-1538.
38. Akhtar N., Ni J., Stromberg D., Rosenthal G.L., Bowles N.E., Towbin J.A. Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis. Circulation Apr 20 1999, 99(15):2011-2018.
39. Carturan E., Milanesi O., Kato Y., et al. Viral detection and tumor necrosis factor alpha profile in tracheal aspirates from children with suspicion of myocarditis. Diagn Mol Pathol Mar 2008, 17(1):21-27.
40. Gandhi S.K., Huddleston C.B., Balzer D.T., Epstein D.J., Boschert T.A., Canter C.E. Biventricular assist devices as a bridge to heart transplantation in small children. Circulation Sep 30 2008, 118(14 Suppl.):S89-S93.
41. Humpl T., Furness S., Gruenwald C., Hyslop C., Van Arsdell G. The Berlin Heart EXCOR Pediatrics-the SickKids Experience 2004-2008. Artif Organs Dec 2010, 34(12):1082-1086. 10.1111/j.1525-1594.2009.00990.x.
42. Jeewa A., Manlhiot C., McCrindle B.W., Van Arsdell G., Humpl T., Dipchand A.I. Outcomes with ventricular assist device versus extracorporeal membrane oxygenation as a bridge to pediatric heart transplantation. Artif Organs Dec 2010, 34(12):1087-1091. 10.1111/j.1525-1594.2009.00969.x.
43. Imamura M., Dossey A.M., Prodhan P., et al. Bridge to cardiac transplant in children: Berlin Heart versus extracorporeal membrane oxygenation. Ann Thorac Surg Jun 2009, 87(6):1894-1901. discussion 1901.
44. Morales D.L., Almond C.S., Jaquiss R.D., et al. Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant Jan 2011, 30(1):1-8.
45. Drucker N.A., Colan S.D., Lewis A.B., et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation Jan 1994, 89(1):252-257.
46. Lee K.J., McCrindle B.W., Bohn D.J., et al. Clinical outcomes of acute myocarditis in childhood. Heart Aug 1999, 82(2):226-233.
47. McNamara D.M., Holubkov R., Starling R.C., Dec G.W., Loh E., Torre-Amione G., Gass A., Janosko K., Tokarczyk T., Kessler P., Mann D.L., Feldman A.M. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation May 8 2001, 103(18):2254-2259.
48. Robinson J., Hartling L., Vandermeer B., Crumley E., Klassen T.P. Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev 2005 Jan 25, (1). CD004370.
49. Klugman D., Berger J.T., Sable C.A., He J., Khandelwal S.G., Slonim A.D. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol Feb 2010, 31(2):222-228.
50. Camargo P.R., Snitcowsky R., da Luz P.L., et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol Mar-Apr 1995, 16(2):61-68.
51. Gagliardi M.G., Bevilacqua M., Bassano C., et al. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart Oct 2004, 90(10):1167-1171.
52. Kleinert S., Weintraub R.G., Wilkinson J.L., Chow C.W. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant Dec 1997, 16(12):1248-1254.
53. Liu C., Chen J., Liu K. Immunosuppressive treatment for inflammatory cardiomyopathy: meta-analysis of randomized controlled trials. Int Heart J Jan 2005, 46(1):113-122.
54. Maisch B., Herzum M., Hufnagel G., Bethge C., Schönian U. Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. Eur Heart J Dec 1995, (16 Suppl. O):153-161.
55. Wojnicz R., Nowalany-Kozielska E., Wojciechowska C., et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation Jul 3 2001, 104(1):39-45.
56. Mason J.W., O'Connell J.B., Herskowitz A., et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med Aug 3 1995, 333(5):269-275.
57. Hia C.P., Yip W.C., Tai B.C., Quek S.C. Immunosuppressive therapy in acute myocarditis: an 18year systematic review. Arch Dis Child Jun 2004, 89(6):580-584.
58. Kishimoto C., Thorp K.A., Abelmann W.H. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis. Circulation Sep 1990, 82(3):982-989.
59. O'Connell J.B., Reap E.A., Robinson J.A. The effects of cyclosporine on acute murine Coxsackie B3 myocarditis. Circulation Feb 1986, 73(2):353-359.
60. Schultheiss H.P., Piper C., Sowade O., et al. The effect of subcutaneous treatment with interferon-beta-1b over 24 weeks on safety, virus elimination and clinical outcome in patients with chronic viral cardiomyopathy. Circulation Nov 25 2008, 118(22):2312. (abstract 3322).
61. Zimmermann O., Rodewald C., Radermacher M., et al. Interferon beta-1b therapy in chronic viral dilated cardiomyopathy-is there a role for specific therapy?. J Card Fail Apr 2010, 16(4):348-356. Epub 2010 Feb 7.
62. Grogan M., Redfield M.M., Bailey K.R., et al. Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol Jul 1995, 26(1):80-84.
63. English R.F., Janosky J.E., Ettedgui J.A., Webber S.A. Outcomes for children with acute myocarditis. Cardiol Young Oct 2004, 14(5):488-493.
64. O'Sullivan J.J., Roche S.L., Crossland D.S., Chaudhari M.P., Kirk R.C., Asif H. Recovery of heart function in children with acute severe heart failure. Transplantation Apr 15 2008, 85(7):975-979.
65. Rhee E.K., Canter C.E., Basile S., Naftel D.C. Sudden cardiac death prior to pediatric heart transplantation: would implantable defibrillators improve outcome?. J Heart Lung Transplant 2007, 26:447-452.
66. Kindermann I., Kindermann M., Kandolf R., et al. Predictors of outcome in patients with suspected myocarditis. Circulation Aug 5 2008, 118(6):639-648. Epub 2008 Jul 21.
67. Freixa X., Sionis A., Castel A., et al. Low troponin-I levels on admission are associated with worse prognosis in patients with fulminant myocarditis. Transplant Proc 2009 Jul-Aug, 41(6):2234-2236.
68. Frustaci A., Chimenti C., Calabrese F., Pieroni M., Thiene G., Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation Feb 18 2003, 107(6):857-863.
69. Angelini A., Crosato M., Boffa G.M., et al. Active versus borderline myocarditis: clinicopathological correlates and prognostic implications. Heart 2002 Mar, 87(3):210-215.
70. Pietra B., Kantor P., Bartlett H., et al. Clinical factors associated with UNOS status and outcome after listing for heart transplantation in children with dilated cardiomyopathy. American Heart Association Annual Meeting 2007, (abstract).
71. Moulik M., Breinholt J.P., Dreyer W.J., et al. Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. J Am Coll Cardiol Aug 10 2010, 56(7):582-592.